Mission raises $13.3m for Parkinson’s mitophagy drug
Longevity Technology - 27-Oct-2025Cambridge biotech to trial USP30 inhibitor MTX325 to boost mitochondrial repair in Parkinson’s
Join the club for FREE to access the whole archive and other member benefits.
Cambridge biotech to trial USP30 inhibitor MTX325 to boost mitochondrial repair in Parkinson’s
Biotech startup Elevara aims to transform RA treatment with a non-immunosuppressive oral drug
Startup aims to add 20 healthy years through advanced epigenetic age testing
NewLimit’s $45M raise advances youthful liver and immune cell restoration in preclinical studies
PP405 shows early promise in reactivating dormant hair follicles to restore growth
Click on resource name for more details.
24-Jun-2026
Aging affects everyone. But what if we could age better and could prevent disease before it starts? (Dublin, Ireland)
Longevity Roadmap Podcast- Karl Pfleger discusses longevity’s evolving science and investment scene
16-Oct-2025
The Alliance for Longevity Initiatives event gathering investors in longevity startups (Los Angeles, CA, USA)
Scotch McClure shares the latest from Maxwell Biosciences
12-Mar-2026
One-day conference for over 350 visitors focused on AI, cybersecurity, and big data (St. Gallen, Switzerland)
Great to see a startup willing to explicitly state they are treating ageing itself as a disease
Adrian reviews a range of finalists trying to track cancer, blood oxygenation, retinal scans, and cardiac health
Skincare product R&D budgets exceed the National Institute on Aging's budget - let's get it focussed on real anti-aging science